Phase I/II trial of oral UFT/Leucovorin (LV) and paclitaxel (P) in the second line treatment of patients (PTS) with metastatic breast cancer (MBC)

被引：0
|
作者：
Klaassen, U [1 ]
Lang, S [1 ]
Borquez, D [1 ]
Oberhoff, C [1 ]
Benner, S [1 ]
Harstrick, A [1 ]
Seeber, S [1 ]
机构：
[1] Univ Essen Gesamthsch, W German Canc Ctr, Dept Int Med Canc Res, Essen, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81710-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1294
引用
收藏
页码：S322 / S323
页数：2
相关论文
共 50 条
  • [31] UFT plus leucovorin (LV) in advanced colorectal cancer (CCR).: A phase II trial.
    Aranda, E
    Antón-Torres, A
    Sastre, J
    Navarro, M
    Rivera, F
    Carrato, A
    Bretón, JJ
    Grávalos, C
    Aparicio, J
    Fernandez-Martos, C
    Díaz-Rubio, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S79 - S79
  • [32] Phase II trial of saracatinib in patients (pts) with ER/PR-negative metastatic breast cancer (MBC)
    Traina, T. A.
    Sparano, J. A.
    Caravelli, J.
    Patil, S.
    Abbruzzi, A.
    Hawke, R.
    Bromberg, J.
    Nonemaker, J.
    Norton, L.
    Hudis, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] PACLITAXEL IN COMBINATION WITH UFT plus LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER: DOSE-FINDING STUDY
    Cecconetto, Lorenzo
    Maltoni, Roberta
    Serra, Patrizia
    Massa, Ilaria
    Ridolfi, Laura
    Ibrahim, Toni
    Passardi, Alessandro
    Ulivi, Paola
    Riva, Nada
    Amadori, Dino
    ANNALS OF ONCOLOGY, 2004, 15 : 23 - 23
  • [34] Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer
    Veronese, ML
    Stevenson, JP
    Sun, W
    Redlinger, M
    Algazy, K
    Giantonio, B
    Hahn, S
    Vaughn, D
    Thorn, C
    Whitehead, AS
    Haller, DG
    O'Dwyer, PJ
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (04) : 508 - 514
  • [35] A phase II trial of dasatinib (D) in combination with trastuzumab (T) and paclitaxel (P) in the first line treatment of HER2 positive metastatic breast cancer (MBC) patients (pts): GEICAM/2010-04
    Ocana Fernandez, A.
    Ruiz Borrego, M.
    Gil Martin, M.
    Antolin, S.
    Atienza, M.
    Montano, A.
    Ribelles, N.
    Guerrero, A.
    Munoz, M.
    Fernandez-Perez, I.
    Urruticoechea, A.
    Falcon Gonzalez, A.
    Pernas Simon, S.
    Prato Varela, J.
    Escudero, M. J.
    Benito, S.
    Caballero, R.
    Carrasco, E.
    Rojo, F.
    Pandiella, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Phase I study of paclitaxel, UFT and leucovorin calcium in patients with metastatic solid tumors.
    Tkaczuk, KH
    Doyle, LA
    Tait, N
    Quinn, C
    Duckham, E
    Buadi, F
    Chen, T
    Edelman, M
    ANNALS OF ONCOLOGY, 2000, 11 : 137 - 137
  • [37] Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer
    Siemerink, Ester J. M.
    Drenth, Annemieke F. J.
    Mulder, Nanno H.
    Plukker, John T. M.
    Hospers, Geke A. P.
    GASTRIC CANCER, 2010, 13 (02) : 95 - 100
  • [38] Phase II trial of paclitaxel polyglumex (PPX) with capecitabine (C) for metastatic breast cancer (MBC)
    Northfelt, D. W.
    Allred, J. B.
    Liu, H.
    Hobday, T. J.
    Rodacker, M. W.
    Lyss, A. P.
    Fitch, T. R.
    Perez, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Phase I/II study of 24-hour infusion of irinotecan (CPT-11) in combination with sequential oral leucovorin (LV) and uracil/tegafur (UFT) for patients (PTS) with metastatic colorectal cancer (MCRC)
    Sadahiro, Sotaro
    Maeda, Yuji
    Suzuki, Toshiyuki
    Makuuchi, Hiroyasu
    Kamijo, Akemi
    Murayama, Chieko
    ANNALS OF ONCOLOGY, 2006, 17 : 117 - 117
  • [40] Results of first-line weekly paclitaxel (P) plus gemcitabine (G) in metastatic breast cancer (MBC): An AERO phase II trial
    Mousseau, M.
    Serin, D.
    Petit, T.
    Priou, F.
    Zelek, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345